Evidence map›Paper›PMID 37179261›Full record

ArticleArchives of dermatological research2023

Combined therapy of local recombinant human interferon α1b injection and acupuncture on verruca vulgaris: a retrospective study.

LiangHong Chen, Yan Wu, Yan Sun, Shuai Qiao, BiHuan Xiao, JingYu Wang, Qian An, XingHua Gao

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of dermatological research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

LiangHong ChenDepartment of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, China.
Yan WuDepartment of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, China.
Yan SunDepartment of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, China. sunyan805@163.com.
Shuai QiaoDepartment of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, China. QS197708@163.com.
BiHuan XiaoDepartment of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, China.
JingYu WangDepartment of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, China.
Qian AnDepartment of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, China.
XingHua GaoDepartment of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, China.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

National Natural Science Foundation of China 81903198National Natural Science Foundation of China 82103758
6 · The paper itself

Abstract

Verruca vulgaris is always stubborn to treat. We applied a new combined therapy of local recombinant human interferon alpha 1b (rhIFNα1b) injection plus acupuncture on verruca vulgaris recently to evaluate the efficacy and safety of the combined therapy. The retrospective study was conducted in The First Hospital of China Medical University from 2018 to 2020. Patients with verruca vulgaris were included. Combined therapy with local rhIFNα1b injection plus acupuncture was set as treatment group, rhIFNα1b injection and carbon dioxide (CO

Indexed as

Acupuncture TherapyWartsCarbon DioxideFemaleHumansInterferon-alphaRetrospective StudiesCarbon DioxideInterferon-alphaAcupunctureHuman papillomavirus (HPV)Recombinant human interferon alpha 1b (rhIFNα1b)Verruca vulgaris

Identifiers

PMID37179261
PMCPMC10182843
OpenAlexW4376612663

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.